While significantly higher sIL6R levels have also been reported in patients with BC [158,159], it has been suggested that larger sample cohorts need to be assessed before conclusions can be drawn regarding the prognostic potential of sIL6R levels in this cancer type [27]. This evidence concerns the gene IL6R and cancer.